Grigioni W F, D'Errico A, Fortunato C, Fiorentino M, Mancini A M, Stetler-Stevenson W G, Sobel M E, Liotta L A, Onisto M, Garbisa S
Pathology Institute, Medical School of Bologna, Italy.
Mod Pathol. 1994 Feb;7(2):220-5.
The extra-cellular matrix (ECM) related antigens, type IV collagen, laminin, M(r) 68,000 laminin receptor (LR), M(r) 72,000 type IV collagenase (MMP-2), its inhibitor TIMP-2, and alpha 2-macroglobulin expression have been immunohistochemically investigated in 100 cases of human gastric carcinoma with a 5-yr follow up. Basement membranes were inversely related to tumoral differentiation. At the early intramucosal stage of both intestinal and diffuse histological types, TIMP-2 was expressed by the majority of tumor cells (60/63%), whereas MMP-2+ and LR+ cells were in the minority (24/19%, 23/0%, respectively). At the early submucosal stage, TIMP-2+ cells moderately decreased in both histological types (49/49%), whereas a consistently higher number of both MMP-2+ and LR+ cells were detected only in the diffuse carcinomas (72%). In the advanced stage, the expression of TIMP-2 further declined (22/24%), although the other two antigens increased or maintained high levels of expression. AMG+ cells never exceeded 10% in either histological type at any stage. In the liver metastases, both MMP-2+ and LR+ cells were more numerous than in the primary tumor (P < 0.002 and P < 0.01). Patients who died from their primary tumor had higher percentages of LR+, MMP-2+, and AMG+ cells and lower percentages of TIMP-2+ cells with respect to survivors. We believe evaluation of ECM-related antigens, and especially TIMP-2, may help determine a confident prognosis for gastric cancer.
对100例人类胃癌患者进行了5年随访,采用免疫组织化学方法研究了细胞外基质(ECM)相关抗原、IV型胶原、层粘连蛋白、分子量68,000的层粘连蛋白受体(LR)、分子量72,000的IV型胶原酶(MMP-2)、其抑制剂TIMP-2和α2-巨球蛋白的表达。基底膜与肿瘤分化呈负相关。在肠型和弥漫型组织学类型的早期黏膜内阶段,大多数肿瘤细胞表达TIMP-2(60/63%),而MMP-2+和LR+细胞占少数(分别为24/19%、23/0%)。在早期黏膜下层阶段,两种组织学类型中TIMP-2+细胞均适度减少(49/49%),而仅在弥漫性癌中检测到MMP-2+和LR+细胞数量持续较高(72%)。在晚期,TIMP-2的表达进一步下降(22/24%),尽管其他两种抗原表达增加或维持在高水平。在任何阶段,两种组织学类型中AMG+细胞均未超过10%。在肝转移灶中,MMP-2+和LR+细胞均比原发肿瘤中更多(P<0.002和P<0.01)。与存活患者相比,死于原发性肿瘤的患者LR+、MMP-2+和AMG+细胞百分比更高,TIMP-2+细胞百分比更低。我们认为,评估ECM相关抗原,尤其是TIMP-2,可能有助于确定胃癌的确切预后。